Effects of noncoding RNAs in radiotherapy response in breast cancer: a systematic review

References

• Azria D, Brengues M, Gourgou S, et al. Personalizing Breast Cancer Irradiation Using Biology: from Bench to the Accelerator. Front Oncol. 2018;8. DOI:10.3389/fonc.2018.00083
   Web of Science ®Google Scholar
• Czochor JR, Glazer PM. microRNAs in cancer cell response to ionizing radiation. Antioxid Redox Signal. 2014;21:293–312.
   PubMed Web of Science ®Google Scholar
• Chaudhry MA. Radiation-induced microRNA: discovery, functional analysis, and cancer radiotherapy. J Cell Biochem. 2014;115:436–449.
   PubMed Web of Science ®Google Scholar
• Malik A, Sultana M, Qazi A, et al. Role of Natural Radiosensitizers and Cancer Cell Radioresistance: an Update. Anal Cell Pathol. 2016;2016:6146595.
   Web of Science ®Google Scholar
• Zhao L, Lu X, Cao Y. MicroRNA and signal transduction pathways in tumor radiation response. Cell Signal. 2013;25:1625–1634.
   PubMed Web of Science ®Google Scholar
• Slodkowska EA, Ross JS. MammaPrint 70-gene signature: another milestone in personalized medical care for breast cancer patients. Expert Rev Mol Diagn. 2009;9:417–422.
   PubMed Web of Science ®Google Scholar
• McVeigh TP, Kerin MJ. Clinical use of the Oncotype DX genomic test to guide treatment decisions for patients with invasive breast cancer. Breast Cancer (Dove Med Press). 2017;9:393–400.
   PubMed Web of Science ®Google Scholar
• Wei W, Lewis MT. Identifying and targeting tumor-initiating cells in the treatment of breast cancer. Endocr Relat Cancer. 2015;22:R135–55.
   PubMed Web of Science ®Google Scholar
• Mueller AK, Lindner K, Hummel R, et al. MicroRNAs and Their Impact on Radiotherapy for Cancer. Radiat Res. 2016;185:668–677.
   PubMed Web of Science ®Google Scholar
• Korpela E, Vesprini D, Liu SK. MicroRNA in radiotherapy: miRage or miRador? Br J Cancer. 2015;112:777–782.
   PubMed Web of Science ®Google Scholar
• Krause M, Dubrovska A, Linge A, et al. Cancer stem cells: radioresistance, prediction of radiotherapy outcome and specific targets for combined treatments. Adv Drug Deliv Rev. 2017;109:63–73.
   PubMed Web of Science ®Google Scholar
• Zhang X, Xie K, Zhou H, et al. Role of non-coding RNAs and RNA modifiers in cancer therapy resistance. Mol Cancer. 2020;19:47.
   PubMed Web of Science ®Google Scholar
• Chaudhry MA, Kreger B, Omaruddin RA. Transcriptional modulation of micro-RNA in human cells differing in radiation sensitivity. Int J Radiat Biol. 2010;86:569–583.
   PubMed Web of Science ®Google Scholar
• Yan Y, Zhang F, Fan Q, et al. Breast cancer-specific TRAIL expression mediated by miRNA response elements of let-7 and miR-122. Neoplasma. 2014;61:672–679.
   PubMed Web of Science ®Google Scholar
• Halimi M, Parsian H, Asghari SM, et al. Clinical translation of human microRNA 21 as a potential biomarker for exposure to ionizing radiation. Transl Res. 2014;163:578–584.
   PubMed Web of Science ®Google Scholar
• Liu J, Zhu H, Yang X, et al. MicroRNA-21 is a novel promising target in cancer radiation therapy. Tumour Biol. 2014;35:3975–3979.
   PubMed Web of Science ®Google Scholar
• Imani S, Zhang X, Hosseinifard H, et al. The diagnostic role of microRNA-34a in breast cancer: a systematic review and meta-analysis. Oncotarget. 2017;8:23177–23187.
   PubMedGoogle Scholar
• Lacombe J, Zenhausern F. Emergence of miR-34a in radiation therapy. Crit Rev Oncol Hematol. 2017;109:69–78.
   PubMed Web of Science ®Google Scholar
• Stankevicins L, Almeida Da Silva AP, Ventura Dos Passos F, et al. MiR-34a is up-regulated in response to low dose, low energy X-ray induced DNA damage in breast cells. Radiat Oncol. 2013;8:231.
   PubMed Web of Science ®Google Scholar
• Kofman AV, Kim J, Park SY, et al. microRNA-34a promotes DNA damage and mitotic catastrophe. Cell Cycle (Georgetown, Tex). 2013;12:3500–3511.
   PubMed Web of Science ®Google Scholar
• Bojmar L, Karlsson E, Ellegård S, et al. The role of microRNA-200 in progression of human colorectal and breast cancer. PLoS One. 2013;8:e84815–e.
   PubMed Web of Science ®Google Scholar
• Wang B, Zheng J, Li R, et al. Long noncoding RNA LINC02582 acts downstream of miR-200c to promote radioresistance through CHK1 in breast cancer cells. Cell Death Dis. 2019;10:764.
   PubMed Web of Science ®Google Scholar
• Sun Q, Liu T, Yuan Y, et al. MiR-200c inhibits autophagy and enhances radiosensitivity in breast cancer cells by targeting UBQLN1. Int J Cancer. 2015;136:1003–1012.
   PubMed Web of Science ®Google Scholar
• Kolenda T, Przybyła W, Teresiak A, et al. The mystery of let-7d - a small RNA with great power. Contemp Oncol (Pozn). 2014;18:293–301.
   PubMedGoogle Scholar
• Wang L, Yuan C, Lv K, et al. Lin28 Mediates Radiation Resistance of Breast Cancer Cells via Regulation of Caspase, H2A.X and Let-7 Signaling. PLoS One. 2013;8:e67373.
   PubMed Web of Science ®Google Scholar
• Sun H, Ding C, Zhang H, et al. Let‑7 miRNAs sensitize breast cancer stem cells to radiation‑induced repression through inhibition of the cyclin D1/Akt1/Wnt1 signaling pathway. Mol Med Rep. 2016;14:3285–3292.
   PubMed Web of Science ®Google Scholar
• Zaleska K, Przybyła A, Kulcenty K, et al. Wound fluids affect miR-21, miR-155 and miR-221 expression in breast cancer cell lines, and this effect is partially abrogated by intraoperative radiation therapy treatment. Oncol Lett. 2017;14:4029–4036.
   PubMed Web of Science ®Google Scholar
• Al-Hajj M, Clarke MF. Self-renewal and solid tumor stem cells. Oncogene. 2004;23:7274–7282.
   PubMed Web of Science ®Google Scholar
• Eun K, Ham SW, Kim H. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting. BMB Rep. 2017;50:117–125.
   PubMed Web of Science ®Google Scholar
• Troschel FM, Böhly N, and Borrmann K, et al. miR-142-3p attenuates breast cancer stem cell characteristics and decreases radioresistance in vitro. tumor biology . 2018;40(1010428318791887). doi:10.1177/1010428318791887
   PubMedGoogle Scholar
• Zhang D, Tang DG, Rycaj K. Cancer stem cells: regulation programs, immunological properties and immunotherapy. Semin Cancer Biol. 2018;52:94–106.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xu B, Zhang X-P. Effects of miRNAs on functions of breast cancer stem cells and treatment of breast cancer. Onco Targets Ther. 2018;11:4263–4270.
   PubMed Web of Science ®Google Scholar
• Khalighfard S, Alizadeh AM, Irani S, et al. Plasma miR-21, miR-155, miR-10b, and Let-7a as the potential biomarkers for the monitoring of breast cancer patients. Sci Rep. 2018;8:17981.
   PubMed Web of Science ®Google Scholar
• Zhang T, Hu H, Yan G, et al. Long Non-Coding RNA and Breast Cancer. Technol Cancer Res Treat. 2019;18:1533033819843889.
   Web of Science ®Google Scholar
• Aranza-Martínez A, Sánchez-Pérez J, Brito-Elias L, et al. Non-Coding RNAs Associated With Radioresistance in Triple-Negative Breast Cancer. Front Oncol. 2021;11:752270.
   PubMed Web of Science ®Google Scholar
• Hu X, Ding D, Zhang J, Cui , J, et al. Knockdown of lncRNA HOTAIR sensitizes breast cancer cells to ionizing radiation through activating miR-218. Biosci Rep. 2019;39(4):BSR20181038. doi: 10.1042/BSR20181038. PMID: 30429228; PMCID: PMC6449517.
   Web of Science ®Google Scholar
• Qian L, Fei Q, Zhang H, et al. lncRNA HOTAIR Promotes DNA Repair and Radioresistance of Breast Cancer via EZH2. DNA Cell Biol. 2020;39(12):2166–2173.
   Web of Science ®Google Scholar
• Zhou Y, Wang C, Liu X, et al. Long non-coding RNA HOTAIR enhances radioresistance in MDA-MB231 breast cancer cells. Oncol Lett. 2017;13:1143–1148.
   PubMed Web of Science ®Google Scholar
• Zhang S, Wang B, Xiao H, et al. LncRNA HOTAIR enhances breast cancer radioresistance through facilitating HSPA1A expression via sequestering miR-449b-5p. Thorac Cancer. 2020;11:1801–1816.
   PubMed Web of Science ®Google Scholar
• Tang Q, Hann SS. HOTAIR: an Oncogenic Long Non-Coding RNA in Human Cancer. Cell Physiol Biochem. 2018;47:893–913.
   PubMedGoogle Scholar
• Chen L, Qian X, Wang Z, et al. The HOTAIR lncRNA: a remarkable oncogenic promoter in human cancer metastasis (Review). Oncol Lett. 2021;21:302.
   PubMed Web of Science ®Google Scholar
• Zhang Y, He Q, Hu Z, et al. Long noncoding RNA LINP1 regulates repair of DNA double-strand breaks in triple-negative breast cancer. Nat Struct Mol Biol. 2016;23:522–530.
   PubMed Web of Science ®Google Scholar
• Lai Y, Chen Y, Lin Y, et al. Down-regulation of LncRNA CCAT1 enhances radiosensitivity via regulating miR-148b in breast cancer. Cell Biol Int. 2018;42:227–236.
   PubMed Web of Science ®Google Scholar
• Zhang N, Zeng X, Sun C, et al. LncRNA LINC00963 Promotes Tumorigenesis and Radioresistance in Breast Cancer by Sponging miR-324-3p and Inducing ACK1 Expression. Mol Ther Nucleic Acids. 2019;18:871–881.
   PubMedGoogle Scholar
• Lv XJ, Tang Q, Tu YQ, et al. Long noncoding RNA PCAT6 regulates cell growth and metastasis via Wnt/β-catenin pathway and is a prognosis marker in cervical cancer. Eur Rev Med Pharmacol Sci. 2019;23:1947–1956.
   PubMed Web of Science ®Google Scholar
• Bi Z, Li Q, Dinglin X, et al. Nanoparticles (NPs)-Meditated LncRNA AFAP1-AS1 Silencing to Block Wnt/β-Catenin Signaling Pathway for Synergistic Reversal of Radioresistance and Effective Cancer Radiotherapy. Adv Sci. 2020;7:2000915.
   Web of Science ®Google Scholar
• Lin L-C, Lee H-T, Chien P-J, et al. NAD(P)H:quinone oxidoreductase 1 determines radiosensitivity of triple negative breast cancer cells and is controlled by long non-coding RNA NEAT1. Int J Med Sci. 2020;17:2214–2224.
   PubMed Web of Science ®Google Scholar
• Leung CM, Chen TW, Li SC, et al. MicroRNA expression profiles in human breast cancer cells after multifraction and single-dose radiation treatment. Oncol Rep. 2014;31:2147–2156.
   PubMed Web of Science ®Google Scholar
• Ren YQ, Fu F, Han J. MiR-27a modulates radiosensitivity of triple-negative breast cancer (TNBC) cells by targeting CDC27. Med Sci Monit. 2015;21:1297–1303.
   PubMed Web of Science ®Google Scholar
• Zhang X, Li Y, Wang D, et al. miR-22 suppresses tumorigenesis and improves radiosensitivity of breast cancer cells by targeting Sirt1. Biol Res. 2017;50:27.
   PubMed Web of Science ®Google Scholar
• Pajic M, Froio D, Daly S, et al. miR-139-5p Modulates Radiotherapy Resistance in Breast Cancer by Repressing Multiple Gene Networks of DNA Repair and ROS Defense. Cancer Res. 2018;78:501–515.
   PubMed Web of Science ®Google Scholar
• Zhang P, Wang L, Rodriguez-Aguayo C, et al. miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13. Nat Commun. 2014;5:5671.
   PubMed Web of Science ®Google Scholar